BioSpace News Archive

Business

Halozyme Reports Third Quarter 2022 Financial and Operating Results

Halozyme Therapeutics, Inc. reported its financial and operating results for the third quarter ended September 30, 2022 and provided an update on its recent corporate activities and outlook.

November 8, 2022
·
21 min read
Business

Berkeley Lights Reports Third Quarter 2022 Financial Results

Berkeley Lights, Inc., a leader in digital cell biology, reported financial results for the quarter ended September 30, 2022.

November 8, 2022
·
7 min read
BioMidwest

Clinicians at 2022 AVA Scientific Meeting Discuss Observed CLABSI-Reductions With SecurePortIV® Adhesive

At the 2022 Association for Vascular Access Annual Scientific Meeting, clinicians reported statistically significant reductions in dressing changes and Central Line-Associated Bloodstream Infections as a result of utilizing Adhezion Biomedical’s SecurePortIV® Catheter Securement Adhesive.

November 8, 2022
·
1 min read
Business

Processa Pharmaceuticals Announces Third Quarter Financial Results and Provides Corporate Update

Processa Pharmaceuticals, Inc. announced financial results for the quarter ended September 30, 2022, and provided an update on its clinical programs.

November 8, 2022
·
5 min read
Business

Assertio Reports Third Quarter 2022 Financial Results

Assertio Holdings, Inc., a specialty pharmaceutical company offering differentiated products to patients, reported financial results for the third quarter ended September 30, 2022.

November 8, 2022
·
18 min read
Business

Assembly Biosciences Reports Third Quarter 2022 Financial Results and Recent Highlights and Announces Upcoming Conference Participation

Assembly Biosciences, Inc., a clinical-stage biotechnology company developing innovative, investigational therapeutics targeting hepatitis B virus and other viral diseases, announced financial results and recent highlights for the third quarter ended September 30, 2022.

November 8, 2022
·
10 min read
Business

Lyra Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update

Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”) today reported its financial results for the third quarter ended September 30, 2022 and provided a corporate update.

November 8, 2022
·
11 min read
Business

Silk Road Medical Reports Third Quarter 2022 Financial Results

Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended September 30, 2022.

November 8, 2022
·
6 min read
Business

Avidity Biosciences Reports Third Quarter 2022 Financial Results and Recent Highlights

Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced financial results for the third quarter ended September 30, 2022 and highlighted recent corporate progress.

November 8, 2022
·
10 min read
Business

JelloX Debut Highlights Potential to Disrupt Cancer Pathology

JelloX Biotech’s debut at Intel® Innovation in September drew the attention of healthcare experts and pharmaceutical brands alike for the Taiwan-based startup’s potential to shape the future of cancer pathology using 3D imaging technology.

November 8, 2022
·
3 min read